Tianda Pharmaceuticals Ltd

Capital Structure and Liquidity Tianda Pharmaceuticals has a market cap of HKD 210.7 million and a price-to-book ratio of 0.46, indicating a significant discount to its book value. The company's liquidity position is characterized by a current ratio of 0.83, suggesting potential short-term liquidity constraints. With cash and equivalents of HKD 64.8 million and long-term debt of HKD 132.7 million, the company has a negative net cash position after subtracting total debt. ### Profitability and Returns The company reported a net loss of HKD 69.9 million and an operating loss of HKD 65.8 million in the latest period, resulting in a negative return on equity of -15.33% and a return on assets of -9.36%. These figures are below the industry median for profitability metrics, indicating underperformance relative to its peers. ### Segments and Geographic Exposure Tianda Pharmaceuticals operates through three segments: Pharmaceuticals and Medical Technologies, Chinese Medicine, and Medical and Healthcare Services. The company's revenue is concentrated in these segments, with no disclosed geographic breakdown. The lack of geographic diversification may expose the company to regional economic or regulatory risks. ### Growth Trajectory The company's revenue of HKD 322.9 million in the latest period does not provide a clear growth trajectory due to the absence of historical data. However, the negative net income and operating income suggest a challenging operating environment. The outlook for the current and next fiscal years is not provided, but the company's financial performance indicates a need for strategic improvements. ### Risk Factors The company faces medium liquidity risk, as indicated by its current ratio of 0.83 and negative net cash position. The risk assessment also highlights a low dilution potential, with no significant dilution sources identified. The debt-to-equity ratio of 0.29 suggests a relatively conservative capital structure, but the negative net income may impact its ability to service debt. ### Recent Events No recent events, filings, or transcripts are provided in the input data to assess the company's recent developments or strategic initiatives.